ABSTRACT
Cefaclor (CCL), a new cephalosporin, was tested in vitro against 602 (271 anaerobic and 331 aerobic) clinical isolates in comparison with cephalothin, cefazolin, cephradine, and cefamandole. Sixteen micrograms of CCL per ml inhibited 68% of all aerobes tested and 80% of the 211 enteropathogenic organisms (Escherichia coli, Salmonella, and Shigella) isolated from cases of infantile diarrhoea. CCL inhibited 88% of gram-positive anaerobic cocci and 72% of Bacteroides other than B. fragilis at a concentration of 16 mug/ml. B. fragilis and Clostridia were resistant to CCL. Increased inoculum of E. coli from 10(5) to 10(9) increased the minimal inhibitory concentration of CCL and cefamandole by fourfold against 7 of the 64 strains tested. All seven were beta-lactamase negative. No antimicrobial synergism was noted between CCL and penicillin. The in vitro efficacy of CCL, an oral cephalosporin, against enteropathogenic E. coli, if proven safe, may be tested in vivo against such infections.
Subject(s)
Bacteria/drug effects , Cephalosporins/pharmacology , Aerobiosis , Anaerobiosis , Drug Synergism , Microbial Sensitivity TestsSubject(s)
Lung Diseases/diagnostic imaging , Actinomycosis/diagnostic imaging , Bacterial Infections/diagnostic imaging , Biopsy, Needle , Endocarditis, Bacterial/complications , Female , Gallium Radioisotopes , Humans , Lung Diseases/diagnosis , Lung Diseases/microbiology , Lung Neoplasms/diagnostic imaging , Pneumonia, Pneumococcal/diagnostic imaging , Radionuclide Imaging , Streptococcal Infections/diagnostic imaging , Suction , Tuberculosis, Pulmonary/diagnostic imagingABSTRACT
Twenty-three patients patients with clinical signs of pulmonary embolic disease and lung infiltrates were studied to determine the value of gallium citrate Ga 67 lung scan in differentiating embolic from inflammatory lung disease. In 11 patients without angiographically proved embolism, only seven had corresponding ventilation-perfusion defects compatible with inflammatory disease. In seven of these 11 patients, the gallium 67 concentration indicated inflammatory disease. In the 12 patients with angiographically proved embolic disease, six had corresponding ventilation-perfusion defects compatible with inflammatory disease. None had an accumulation of 67Ga in the area of pulmonary infiltrate. Thus, ventilation-perfusion lung scans are of limited value when lung infiltrates are present. In contrast, the accumulation of 67Ga in the lung indicates an inflammatory process. Gallium imaging can help select those patients with lung infiltrates who need angiography.
